Definitive Healthcare (NASDAQ:DH) Sees Strong Trading Volume

Definitive Healthcare Corp. (NASDAQ:DHGet Free Report) shares saw unusually-high trading volume on Thursday . Approximately 2,154,914 shares were traded during mid-day trading, an increase of 243% from the previous session’s volume of 628,710 shares.The stock last traded at $5.05 and had previously closed at $5.35.

Analyst Ratings Changes

DH has been the subject of several research analyst reports. Barclays reduced their price target on shares of Definitive Healthcare from $11.00 to $7.00 and set an “equal weight” rating for the company in a report on Thursday. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating on the stock in a research report on Thursday. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Wednesday. Morgan Stanley lowered shares of Definitive Healthcare from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $11.50 to $9.00 in a research report on Wednesday. Finally, Stifel Nicolaus cut their price objective on shares of Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating on the stock in a research report on Wednesday. Nine analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $9.94.

View Our Latest Stock Analysis on Definitive Healthcare

Definitive Healthcare Stock Performance

The firm’s 50-day moving average is $7.54 and its 200 day moving average is $8.26. The company has a current ratio of 2.30, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DHGet Free Report) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The firm had revenue of $65.93 million during the quarter, compared to analyst estimates of $66.01 million. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. On average, analysts expect that Definitive Healthcare Corp. will post 0.11 earnings per share for the current fiscal year.

Institutional Trading of Definitive Healthcare

Institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its holdings in shares of Definitive Healthcare by 11.7% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,090,136 shares of the company’s stock worth $8,710,000 after buying an additional 113,963 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Definitive Healthcare by 6.2% in the 3rd quarter. Vanguard Group Inc. now owns 4,331,543 shares of the company’s stock worth $34,609,000 after buying an additional 254,726 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in shares of Definitive Healthcare by 7.5% in the 3rd quarter. Eagle Asset Management Inc. now owns 784,230 shares of the company’s stock worth $6,266,000 after buying an additional 54,590 shares during the last quarter. Raymond James & Associates boosted its holdings in shares of Definitive Healthcare by 24.2% in the 3rd quarter. Raymond James & Associates now owns 650,327 shares of the company’s stock worth $5,196,000 after buying an additional 126,613 shares during the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Definitive Healthcare by 209.8% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,209 shares of the company’s stock valued at $161,000 after purchasing an additional 10,977 shares during the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

See Also

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.